On the occasion of the 10th anniversary of the Frida relaunch in the U.S., CEO Chelsea Hirschhorn looks back at the "blind ...

Spravato, a newly FDA-approved nasal spray, offers hope for individuals with treatment-resistant depression, a condition ...

Doctors shared their must-have sick season buys with The Post, revealing which medicines, supplements and tools you should ...

Mouth taping offers sleep benefits but has some potential risks. Learn how to mouth-tape safely and other options to reduce ...

NEW YORK - Tiziana Life Sciences Ltd. (NASDAQ:TLSA), a biotech firm focused on immunomodulation therapies with a market ...

A nasal spray therapy for treatment-resistant major depressive disorder (MDD) has now been approved by the Food and Drug ...

Yes, allergies can make you feel tired. Fatigue is a common allergy symptom, and it’s caused by factors like inflammation or ...

With an MLS-heavy roster, new coach Mauricio Pochettino has plenty to be impressed with after a convincing pair of friendlies ...

The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ...

In today's Health Alert, the FDA has approved the first stand-alone nasal spray to treat drug-resistant depression.